References
- Bixler EO, Vgontzas AN, Lin HM et al. Insomnia in central Pennsylvania. J. Psychosom. Res.53(1), 589–592 (2002).
- Roth T, Jaeger S, Jin R et al. Sleep problems, comorbid mental disorders, and role functioning in the national comorbidity survey replication. Biol. Psychiatry60(12), 1364–1371 (2006).
- Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med. Rev.6(2), 97–111 (2002).
- Walsh JK. Clinical and socioeconomic correlates of insomnia. J. Clin. Psychiatry65(Suppl. 8), 13–19 (2004).
- Ohayon MM. Nocturnal awakenings and comorbid disorders in the American general population. J. Psychiatr. Res.43(1), 48–54 (2008).
- Roth T, Mayleben D, Corser BC et al. Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate. Hum. Psychopharmacol.23(1), 13–20 (2008).
- Ambien®, package insert. Sanofi–Aventis, NJ, USA (2008)
- Patat A, Trocherie S, Thebault JJ et al. EEG profile of intravenous zolpidem in healthy volunteers. Psychopharmacology (Berl.)114(1), 138–146 (1994).
- Roth T, Krystal A, Maguire YP et al. Pharmacokinetics of the sublingual zolpidem tartrate 3.5 mg lozenge compared to the oral zolpidem tartrate 10 mg tablet. Sleep31(Suppl.), abstract 235 (2008).
- Krystal A, Kahn R, Maguire YP et al. A pharmacokinetic study of the co-administration of a high fat meal with a low dose, sublingual formulation of zolpidem tartrate. Sleep.31(Suppl.), abstract 34 (2008).
- Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I). Clin. Pharmacokinet.21(3), 165–177 (1991).
- Krystal A, Scharf M, Mordy C et al. Pharmacokinetics of a low dose, sublingual formulation of zolpidem tartrate in elderly subjects. Sleep.31(Suppl.), abstract 234 (2008).
- Roth T, Hull SG, Lankford DA et al. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings. Sleep31(9), 1277–1284 (2008).
Websites
- US FDA approval of zolpidem tartrate generics www.fda.gov/bbs/topics/news/2007/new01616.html
- NovaDel approval announcement www.integratir.com/newsrelease.asp?news=2131022053&ticker=NVD&lang=EN
- Orexo Edular approval reference www.orexo.com/DynPage.aspx?id=17488&pid=181894